Keratinocyte-intrinsic BCL10/MALT1 activity initiates and amplifies psoriasiform skin inflammation.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
26 Nov 2021
Historique:
entrez: 26 11 2021
pubmed: 27 11 2021
medline: 8 3 2022
Statut: ppublish

Résumé

Psoriasis is a chronic inflammatory skin disease arising from poorly defined pathological cross-talk between keratinocytes and the immune system. BCL10 (B cell lymphoma/leukemia 10) and MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) are ubiquitously expressed inflammatory signaling proteins that can interact with the psoriasis susceptibility factor CARD14, but their functions in psoriasis are insufficiently understood. We report that although keratinocyte-intrinsic BCL10/MALT1 deletions completely rescue inflammatory skin pathology triggered by germline

Identifiants

pubmed: 34826258
doi: 10.1126/sciimmunol.abi4425
doi:

Substances chimiques

B-Cell CLL-Lymphoma 10 Protein 0
Bcl10 protein, mouse 0
Malt1 protein, mouse EC 3.4.22.-
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabi4425

Auteurs

Zsuzsanna Kurgyis (Z)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.
Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.

Larsen Vornholz (L)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.

Konstanze Pechloff (K)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.

Lajos V Kemény (LV)

Cutaneous Biology Research Center, Department of Dermatology and MGH Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Department of Dermatology, Venereology, and Dermatooncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.

Tim Wartewig (T)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.

Andreas Muschaweckh (A)

Department of Experimental Neuroimmunology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Abhinav Joshi (A)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.

Katja Kranen (K)

Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.

Lara Hartjes (L)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.

Sigrid Möckel (S)

Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
Institute of Pathology, Universität Würzburg, Würzburg, Germany.

Katja Steiger (K)

Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany.

Erik Hameister (E)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.

Thomas Volz (T)

Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.

Mark Mellett (M)

Department of Dermatology, University Hospital of Zürich, University of Zurich (UZH), Zürich, Switzerland.

Lars E French (LE)

Department of Dermatology, University Hospital of Zürich, University of Zurich (UZH), Zürich, Switzerland.
Department of Dermatology and Allergy, University Hospital, LMU Munich Munich, Germany.
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Tilo Biedermann (T)

Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.

Thomas Korn (T)

Department of Experimental Neuroimmunology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Jürgen Ruland (J)

Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.
German Center for Infection Research (DZIF), Munich partner site, Munich Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH